Noveris Health Sciences is trading 5.88% up at CA$0.09, with no clear company-specific catalyst identified for September 16, 2026.

  • The latest located announcement was September 4 annual-meeting results, published September 9, rather than a new September 16 event.
  • The broader biotech sector is declining, so sector weakness does not explain the gain.
  • The move may reflect low-priced-stock volatility or trading activity, but the catalyst remains unconfirmed.